"2" . "5"^^ . "http://www.medvik.cz/bmc/view.do?gid=858768" . . . "O, Z(MSM0021622402)" . "1"^^ . "Prevalence diabetiku mellitu (DM) 2. typu v sou\u010Dasn\u00E9 dob\u011B stoup\u00E1 ve v\u0161ech vysp\u011Bl\u00EDch zem\u00EDch sv\u011Bta v\u010Detn\u011B \u010Cesk\u00E9 republiky. Z\u00E1rove\u0148 se zvy\u0161uje v\u00FDskyt chronick\u00FDch komplikac\u00ED, mezi n\u011B\u017E pat\u0159\u00ED mikro- a makrovaskul\u00E1rn\u00ED komplikace, kter\u00E9 jsou u diabetik\u016F hlavn\u00ED p\u0159\u00ED\u010Dinou \u00FAmrt\u00ED. Pokud jim chceme p\u0159edch\u00E1zet, pak mus\u00EDme DM v\u010Das diagnostikovat a p\u0159edev\u0161\u00EDm v\u010Das l\u00E9\u010Dit. Z\u00E1kladn\u00EDm l\u00E9\u010Divem je metformin, kter\u00FD by m\u011Bl b\u00FDt pod\u00E1v\u00E1n prakticky v\u0161em pacient\u016Fm s prediabetem a DM 2. typu. V\u00FDjimku p\u0159edstavuj\u00ED pacienti, u kter\u00FDch se projev\u00ED gastrointestin\u00E1ln\u00ED vedlej\u0161\u00ED \u00FA\u010Dinky nebo zhor\u0161en\u00ED ren\u00E1ln\u00EDch funkc\u00ED. Vzhledem k tomu, \u017Ee diabetici jsou ohro\u017Eeni zv\u00FD\u0161en\u00FDm kardiovaskul\u00E1rn\u00EDm rizikem, je t\u0159eba st\u00E1le p\u0159ipom\u00EDnat dob\u0159e dolo\u017Een\u00E9 pozitivn\u00ED kardiovaskul\u00E1rn\u00ED \u00FA\u010Dinky metforminu." . "diabetes mellitus, cardiovascular complications, type 2 diabetes management, metformin"@en . . . "[CAAA452B3576]" . "Sou\u010Dek, Miroslav" . . "190697" . "Remedia" . . "Co by m\u011Bl kardiolog v\u011Bd\u011Bt o diabetu mellitu 2.typu a l\u00E9\u010Db\u011B peror\u00E1ln\u00EDmi antidiabetiky" . "CZ - \u010Cesk\u00E1 republika" . "21" . "The prevalence of type 2 diabetes mellitus (DM) is currently increasing in all developed countries of the world including the Czech Republic. At the same time, an upward trend is observed in the rates of chronic complications in general and in micro- and macrovascular complications as the major cause of death in diabetic patients in particular. To prevent the complications, DM needs to be diagnosed and treated as early as possible. The first-line therapy is metformin that should be given to practically all pre-diabetic and type 2 diabetic patients. The only exception are the patients who develop gastrointestinal adverse events or experience impairment of renal function. Since diabetic patients are at increased cardiovascular risk, the well-documented cardiovascular benefits of metformin should always be underlined."@en . . . . "0862-8947" . . "Co by m\u011Bl kardiolog v\u011Bd\u011Bt o diabetu mellitu 2.typu a l\u00E9\u010Db\u011B peror\u00E1ln\u00EDmi antidiabetiky"@cs . "RIV/00159816:_____/11:#0000798" . "What a cardilogist should know about type 2 diabetes mellitus and oral antidiabetic therapy?"@en . . "Co by m\u011Bl kardiolog v\u011Bd\u011Bt o diabetu mellitu 2.typu a l\u00E9\u010Db\u011B peror\u00E1ln\u00EDmi antidiabetiky"@cs . "RIV/00159816:_____/11:#0000798!RIV12-MZ0-00159816" . . . . . "Co by m\u011Bl kardiolog v\u011Bd\u011Bt o diabetu mellitu 2.typu a l\u00E9\u010Db\u011B peror\u00E1ln\u00EDmi antidiabetiky" . . . "1"^^ . . "What a cardilogist should know about type 2 diabetes mellitus and oral antidiabetic therapy?"@en . "Prevalence diabetiku mellitu (DM) 2. typu v sou\u010Dasn\u00E9 dob\u011B stoup\u00E1 ve v\u0161ech vysp\u011Bl\u00EDch zem\u00EDch sv\u011Bta v\u010Detn\u011B \u010Cesk\u00E9 republiky. Z\u00E1rove\u0148 se zvy\u0161uje v\u00FDskyt chronick\u00FDch komplikac\u00ED, mezi n\u011B\u017E pat\u0159\u00ED mikro- a makrovaskul\u00E1rn\u00ED komplikace, kter\u00E9 jsou u diabetik\u016F hlavn\u00ED p\u0159\u00ED\u010Dinou \u00FAmrt\u00ED. Pokud jim chceme p\u0159edch\u00E1zet, pak mus\u00EDme DM v\u010Das diagnostikovat a p\u0159edev\u0161\u00EDm v\u010Das l\u00E9\u010Dit. Z\u00E1kladn\u00EDm l\u00E9\u010Divem je metformin, kter\u00FD by m\u011Bl b\u00FDt pod\u00E1v\u00E1n prakticky v\u0161em pacient\u016Fm s prediabetem a DM 2. typu. V\u00FDjimku p\u0159edstavuj\u00ED pacienti, u kter\u00FDch se projev\u00ED gastrointestin\u00E1ln\u00ED vedlej\u0161\u00ED \u00FA\u010Dinky nebo zhor\u0161en\u00ED ren\u00E1ln\u00EDch funkc\u00ED. Vzhledem k tomu, \u017Ee diabetici jsou ohro\u017Eeni zv\u00FD\u0161en\u00FDm kardiovaskul\u00E1rn\u00EDm rizikem, je t\u0159eba st\u00E1le p\u0159ipom\u00EDnat dob\u0159e dolo\u017Een\u00E9 pozitivn\u00ED kardiovaskul\u00E1rn\u00ED \u00FA\u010Dinky metforminu."@cs .